 Amicus Therapeutics Inc. NASDAQ:FOLD Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Bradley Campbell - President, Chief Executive Officer Sébastien Martel - Chief Business Officer Jeff Castelli - Chief Development Officer Daphne Quimi - Chief Financial Officer Andrew Faughnan - Executive Director, Investor Relations Conference Call Participants Ritu Baral - Cowen Anupam Rama - JP Morgan Joseph Schwartz - SVB Securities Tazeen Ahmad - Bank of America Sarah - UBS Dae Gon Ha - Stifel Salveen Richter - Goldman Sachs Yun Zhong - BTIG Gil Blum - Needham Co. Operator Good morning ladies and gentlemen and welcome to the Amicus Therapeutics third quarter 2022 financial results conference call and webcast. At this time, all participants are in a listen-only mode. 